ونحن نستخدم ملفات تعريف الارتباط لتحسين تجربتك. قبل استخدامك المستمر لهذا الموقع يمكنك قبول مثل هذا الاستخدام.
العودة
Merck KGaA

  • المحتوى الإعلامي

  • صور (4)
    • Stefan Oschmann, CEO-elect of Merck
    • Dr Karim Bendhaou (President, North & West Africa, Merck), H.E. Ingo Herbert (German Consul General in Lagos - Consulate General of the Federal Republic of Germany Lagos) and Dr. Stefan Oschmann (CEO-elect CEO-elect of Merck) and Charles Ajibo (General Manager Nigeria – Merck – Biopharma)
    • Dr Stefan Oschmann (CEO-elect CEO-elect of Merck), Prof. François-Xavier Mbopi-Keou (Full Professor of Laboratory Medicine, Microbiology & Infectious Diseases – University of Yaoundé I – Cameroon) and Philippe Durbiano (Senior Manager Bioscience EMEA - Merck – Life Science)
    • Dr Karim Bendhaou (President, North & West Africa, Merck), Dr. Bridget Okoeguale (Director Public Health, Federal Ministry of Health), Charles Ajibo (General Manager Nigeria – Merck – Biopharma) and Dr. Stefan Oschmann (CEO-elect CEO-elect of Merck)
  • الجميع (4)
المصدر: Merck KGaA |

Also available in English, Egalement disponible en Français

DUBAI, United Arab Emirates, نوفمبر 18/APO (African Press Organization)/ --

زعتها APO Group نيابة عن Merck KGaA.

Stefan Oschmann, CEO-elect of Merck

Dr Karim Bendhaou (President, North & West Africa, Merck), H.E. Ingo Herbert (German Consul General in Lagos - Consulate General of the Federal Republic of Germany Lagos) and Dr. Stefan Oschmann (CEO-elect CEO-elect of Merck) and Charles Ajibo (General Manager Nigeria – Merck – Biopharma)

Dr Stefan Oschmann (CEO-elect CEO-elect of Merck), Prof. François-Xavier Mbopi-Keou (Full Professor of Laboratory Medicine, Microbiology & Infectious Diseases – University of Yaoundé I – Cameroon) and Philippe Durbiano (Senior Manager Bioscience EMEA - Merck – Life Science)

Dr Karim Bendhaou (President, North & West Africa, Merck), Dr. Bridget Okoeguale (Director Public Health, Federal Ministry of Health), Charles Ajibo (General Manager Nigeria – Merck – Biopharma) and Dr. Stefan Oschmann (CEO-elect CEO-elect of Merck)